Literature DB >> 8419031

Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection.

T Niwa1.   

Abstract

We developed a simple and sensitive high-performance liquid chromatographic (HPLC) method that uses fluorescence as a detector for quantifying serum phenol and p-cresol in uremic patients on hemodialysis. Identification of phenol and p-cresol was confirmed by liquid chromatography/mass spectrometry. Because the HPLC method requires only simple extraction by ethyl acetate and does not require further steps such as derivatization, it is simple and rapid compared with gas chromatography or gas chromatography/mass spectrometry. Concentrations of phenol and p-cresol in uremic serum were significantly (p < 0.01) higher than those in normal serum. Reduction rates of phenol and p-cresol by hemodialysis were lower than those of urea and creatinine, suggesting a protein-binding property of phenol and p-cresol. This method will be useful for monitoring serum phenols in dialyzed patients as an index of hemodialysis adequacy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419031

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

1.  The intestinal uptake of phenol from micellar systems does not conform to the aqueous transfer model.

Authors:  P A Kothare; C L Zimmerman
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

2.  Fiber supplementation lowers plasma p-cresol in chronic kidney disease patients.

Authors:  Younis A Salmean; Mark S Segal; Sergiu P Palii; Wendy J Dahl
Journal:  J Ren Nutr       Date:  2014-11-05       Impact factor: 3.655

Review 3.  The membrane perspective of uraemic toxins: which ones should, or can, be removed?

Authors:  Sudhir K Bowry; Peter Kotanko; Rainer Himmele; Xia Tao; Michael Anger
Journal:  Clin Kidney J       Date:  2021-12-27

4.  Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD.

Authors:  Jakk Wong; Yvette M Piceno; Todd Z DeSantis; Madeleine Pahl; Gary L Andersen; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2014-03-08       Impact factor: 3.754

Review 5.  Protein-bound uremic toxins: new insight from clinical studies.

Authors:  Sophie Liabeuf; Tilman B Drüeke; Ziad A Massy
Journal:  Toxins (Basel)       Date:  2011-07-20       Impact factor: 4.546

6.  Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients.

Authors:  Suguru Yamamoto; Junichiro J Kazama; Kentaro Omori; Koji Matsuo; Yoshimitsu Takahashi; Kazuko Kawamura; Takayuki Matsuto; Hiroshi Watanabe; Toru Maruyama; Ichiei Narita
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

7.  Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites.

Authors:  Yuki Saito; Tadashi Sato; Koji Nomoto; Hirokazu Tsuji
Journal:  FEMS Microbiol Ecol       Date:  2018-09-01       Impact factor: 4.194

8.  Consecutive Intake of Fermented Milk Containing Bifidobacterium breve Strain Yakult and Galacto-oligosaccharides Benefits Skin Condition in Healthy Adult Women.

Authors:  Mitsuyoshi Kano; Norie Masuoka; Chiaki Kaga; Saho Sugimoto; Ryoko Iizuka; Katsuyuki Manabe; Toshiro Sone; Kazutoshi Oeda; Chiaki Nonaka; Kouji Miyazaki; Fumiyasu Ishikawa
Journal:  Biosci Microbiota Food Health       Date:  2013-01-31

9.  Role of Gut-derived Uremic Toxins on Oxidative Stress and Inflammation in Patients with Chronic Kidney Disease.

Authors:  S Gouroju; P V L N Srinivasa Rao; A R Bitla; K S Vinapamula; S M Manohar; S Vishnubhotla
Journal:  Indian J Nephrol       Date:  2017 Sep-Oct

10.  Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia.

Authors:  Libin Pan; Pei Han; Shurong Ma; Ran Peng; Can Wang; Weijia Kong; Lin Cong; Jie Fu; Zhengwei Zhang; Hang Yu; Yan Wang; Jiandong Jiang
Journal:  Acta Pharm Sin B       Date:  2019-10-30       Impact factor: 11.413

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.